Does exposure to chronic stress influence blood pressure in rats?

Autonomic Neuroscience: Basic and Clinical

Volumn 177, Issue 2, 2013, Pages 217-223

  Bobrovskaya, Larisa ^a   Beard, Daniel ^a   Bondarenko, Evgeny ^a   Beig, Mirza I ^a   Jobling, Phillip ^a   Walker, Frederick R ^a   Day, Trevor A ^a,b   Nalivaiko, Eugene ^a  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

Adrenal gland; Angiotensin receptor; Blood pressure; Footshock stress; Sympathetic ganglia; Tyrosine hydroxylase

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ADRENAL GLAND; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; ELECTRIC SHOCK; ENZYME PHOSPHORYLATION; FOOTSHOCK; HEART RATE; LOCOMOTION; LONG TERM EXPOSURE; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSE PRESSURE; RAT; SHAM PROCEDURE; SOCIAL INTERACTION; SYMPATHETIC GANGLION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TELEMETRY; WEIGHT GAIN;

ADRENAL GLAND; ANG II; ANGIOTENSIN II; ANGIOTENSIN II RECEPTOR TYPE 1; ANGIOTENSIN RECEPTOR; AP; ARTERIAL PRESSURE; AT1R; BLOOD PRESSURE; FOOTSHOCK; FOOTSHOCK STRESS; FS; SER; SERINE RESIDUE; SYMPATHETIC GANGLIA; TH; TYROSINE HYDROXYLASE;

ANIMALS; BLOOD PRESSURE; CHRONIC DISEASE; HEART RATE; MALE; MOTOR ACTIVITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL;

EID: 84883811632     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2013.05.001     Document Type: Article

References (48)

1. Aguilera G., Kiss A., Sunar-Akbasak B. Hyperreninemic hypoaldosteronism after chronic stress in the rat. J. Clin. Invest. 1995, 96:1512-1519.
2. Alicandri C.L., Fariello R., Agabiti-Rosei E., Romanelli G., Muiesan G. Influence of the sympathetic nervous system on aortic compliance. Clin. Sci. (Lond.) 1980, 59(Suppl. 6):279s-282s.
3. Baruchin A., Weisberg E.P., Miner L.L., Ennis D., Nisenbaum L.K., Naylor E., Stricker E.M., Zigmond M.J., Kaplan B.B. Effects of cold exposure on rat adrenal tyrosine hydroxylase: an analysis of RNA, protein, enzyme activity, and cofactor levels. J. Neurochem. 1990, 54:1769-1775.
4. Beig M.I., Callister R., Saint D.A., Bondarenko E., Walker F.R., Day T.A., Nalivaiko E. Voluntary exercise does not affect stress-induced tachycardia, but improves resistance to cardiac arrhythmias in rats. Clin. Exp. Pharmacol. Physiol. 2011, 38:19-26.
5. Bobrovskaya L., Gilligan C., Bolster E.K., Flaherty J.J., Dickson P.W., Dunkley P.R. Sustained phosphorylation of tyrosine hydroxylase at serine 40: a novel mechanism for maintenance of catecholamine synthesis. J. Neurochem. 2007, 100:479-489.
6. Bobrovskaya L., Damanhuri H.A., Ong L.K., Schneider J.J., Dickson P.W., Dunkley P.R., Goodchild A.K. Signal transduction pathways and tyrosine hydroxylase regulation in the adrenal medulla following glucoprivation: an in vivo analysis. Neurochem. Int. 2010, 57:162-167.
7. Bunn S.J., Marley P.D. Effects of angiotensin-II in cultured, bovine adrenal-medullary cells. Neuropeptides 1989, 13:121-132.
8. Castren E., Saavedra J.M. Angiotensin II receptors in paraventricular nucleus, subfornical organ, and pituitary gland of hypophysectomized, adrenalectomized, and vasopressin-deficient rats. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:725-729.
9. Cecchi M., Khoshbouei H., Morilak D.A. Modulatory effects of norepinephrine, acting on alpha 1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology 2002, 43:1139-1147.
10. Cierco M., Israel A. Role of angiotensin AT(1) receptor in the cardiovascular-response to footshock. Eur. J. Pharmacol. 1994, 251:103-106.
11. Cullen W.K., Rowan M.J. Gepirone and 1-(2-pyrimidinyl)-piperazine-induced reduction of aversively evoked ultrasonic vocalisation in the rat. Pharmacol. Biochem. Behav. 1994, 48:301-306.
12. Cuomo V., Cagiano R., De Salvia M.A., Mazzoccoli M., Persichella M., Renna G. Ultrasonic vocalization as an indicator of emotional state during active avoidance learning in rats. Life Sci. 1992, 50:1049-1055.
13. Damanhuri H.A., Burke P.G., Ong L.K., Bobrovskaya L., Dickson P.W., Dunkley P.R., Goodchild A.K. Tyrosine hydroxylase phosphorylation in catecholaminergic brain regions: a marker of activation following acute hypotension and glucoprivation. PLoS One 2012, 7:e50535.
14. Dendorfer A., Thornagel A., Raasch W., Grisk O., Tempel K., Dominiak P. Angiotensin II induces catecholamine release by direct ganglionic excitation. Hypertension 2002, 40:348-354.
15. Dumont E.C., Rafrafi S., Laforest S., Drolet G. Involvement of central angiotensin receptors in stress adaptation. Neuroscience 1999, 93:877-884.
16. Dunkley P.R., Bobrovskaya L., Graham M.E., von Nagy-Felsobuki E.I., Dickson P.W. Tyrosine hydroxylase phosphorylation: regulation and consequences. J. Neurochem. 2004, 91:1025-1043.
17. File S.E., Seth P. A review of 25years of the social interaction test. Eur. J. Pharmacol. 2003, 463:35-53.
18. Fluharty S.J., Snyder G.L., Stricker E.M., Zigmond M.J. Short- and long-term changes in adrenal tyrosine hydroxylase activity during insulin-induced hypoglycemia and cold stress. Brain Res. 1983, 267:384-387.
19. Gelsema A.J., Schoemaker R.G., Ruzicka M., Copeland N.E. Cardiovascular effects of social stress in borderline hypertensive rats. J. Hypertens. 1994, 12:1019-1028.
20. Goldberg P.B., Tumer N., Roberts J. Effect of increasing age on adrenergic control of heart rate in the rat. Exp Gerontol 1988, 23(2):115-125.
21. Gordon S.L., Bobrovskaya L., Dunkley P.R., Dickson P.W. Differential regulation of human tyrosine hydroxylase isoforms 1 and 2 in situ: isoform 2 is not phosphorylated at Ser35. Biochim. Biophys. Acta 2009, 1793:1860-1867.
22. Grassi G., Quarti-Trevano F., Dell'oro R., Mancia G. Essential hypertension and the sympathetic nervous system. Neurol. Sci. 2008, 29(Suppl. 1):S33-S36.
23. Grassi G., Seravalle G., Quarti-Trevano F. The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp. Physiol. 2010, 95:581-586.
24. Grippo A.J., Johnson A.K. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009, 12:1-21.
25. Grippo A.J., Beltz T.G., Johnson A.K. Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol. Behav. 2003, 78:703-710.
26. Grundt A., Grundt C., Gorbey S., Thomas M.A., Lemmer B. Strain-dependent differences of restraint stress-induced hypertension in WKY and SHR. Physiol. Behav. 2009, 97:341-346.
27. Hammen C. Stress and depression. Annu. Rev. Clin. Psychol. 2005, 1:293-319.
28. Head G.A., Mayorov D.N. Central angiotensin and baroreceptor control of circulation. Ann. N. Y. Acad. Sci. 2001, 940:361-379.
29. Henry J.P., Cassel J.C. Psychosocial factors in essential hypertension. Recent epidemiologic and animal experimental evidence. Am. J. Epidemiol. 1969, 90:171-200.
30. Kvetnansky R., Micutkova L., Rychkova N., Kubovcakova L., Mravec B., Filipenko M., Sabban E.L., Krizanova O. Quantitative evaluation of catecholamine enzymes gene expression in adrenal medulla and sympathetic ganglia of stressed rats. Ann. N. Y. Acad. Sci. 2004, 1018:356-369.
31. Lee R.M., Borkowski K.R., Leenen F.H., Tsoporis J., Coughlin M. Interaction between sympathetic nervous system and adrenal medulla in the control of cardiovascular changes in hypertension. J. Cardiovasc. Pharmacol. 1991, 17(Suppl. 2):S114-S116.
32. Lemaire V., Mormède P. Telemetered recording of blood pressure and heart rate in different strains of rats during chronic social stress. Physiol. Behav. 1995, 58:1181-1188.
33. Ma X., Chapleau M.W., Whiteis C.A., Abboud F.M., Bielefeldt K. Angiotensin selectively activates a subpopulation of postganglionic sympathetic neurons in mice. Circ. Res. 2001, 88:787-793.
34. Maier S.F. Learned helplessness and animal models of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 1984, 8:435-446.
35. Minami N., Imai Y., Munakata M., Sasaki S., Sekino H., Abe K., Yoshinaga K. Age-related changes in blood pressure, heart rate and baroreflex sensitivity in SHR. Clin Exp Pharmacol Physiol Suppl 1989, 15:85-87.
36. Nalivaiko E. Animal models of psychogenic cardiovascular disorders: what we can learn from them and what we cannot. Clin. Exp. Pharmacol. Physiol. 2011, 38:115-125.
37. Nankova B., Kvetnansky R., Hiremagalur B., Sabban B., Rusnak M., Sabban E.L. Immobilization stress elevates gene expression for catecholamine biosynthetic enzymes and some neuropeptides in rat sympathetic ganglia: effects of adrenocorticotropin and glucocorticoids. Endocrinology 1996, 137:5597-5604.
38. Overstreet D.H., Griebel G. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression. Eur. J. Pharmacol. 2004, 497:49-53.
39. Parati G., Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur. Heart J. 2012, 33:1058-1066.
40. Pickering T.G. Reflections in hypertension: work and blood pressure. J. Clin. Hypertens. 2004, 6:403-405.
41. Powis D.A., Obrien K.J. Angiotensin-II increases catecholamine release from bovine adrenal-medulla but does not enhance that evoked by K+ depolarisation or by carbachol. J. Neurochem. 1991, 57:1461-1469.
42. Schnall P.L., Schwartz J.E., Landsbergis P.A., Warren K., Pickering T.G. Relation between job strain, alcohol, and ambulatory blood pressure. Hypertension 1992, 19:488-494.
43. Starr K.R., Price G.W., Watson J.M., Atkinson P.J., Arban R., Melotto S., Dawson L.A., Hagan J.J., Upton N., Duxon M.S. SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test. Neuropsychopharmacology 2007, 32:2163-2172.
44. Steenland K., Fine L., Belkic K., Landsbergis P., Schnall P., Baker D., Theorell T., Siegrist J., Peter R., Karasek R., Marmot M., Brisson C., Tuchsen F. Research findings linking workplace factors to CVD outcomes. Occup. Med. 2000, 15:7-68.
45. Stromberg C., Tsutsumi K., Viswanathan M., Saavedra J.M. Angiotensin II AT1 receptors in rat superior cervical ganglia: characterization and stimulation of phosphoinositide hydrolysis. Eur. J. Pharmacol. 1991, 208:331-336.
46. Timio M., Verdecchia P., Venanzi S., Gentili S., Ronconi M., Francucci B., Montanari M., Bichisao E. Age and blood pressure changes. A 20-year follow-up study in nuns in a secluded order. Hypertension 1988, 12:457-461.
47. Van Acker S.A., Fluttert M.F., Sibug R.M., De Kloet E.R. Intracerebroventricular administration of a glucocorticoid receptor antagonist enhances the cardiovascular responses to brief restraint stress. Eur. J. Pharmacol. 2001, 430:87-91.
48. Yang G., Xi Z.X., Wan Y., Wang H., Bi G. Changes in circulating and tissue angiotensin II during acute and chronic stress. Biol. Signals 1993, 2:166-172.